Biotech Showcase 2022: Healing the Psyche with Psychedelia
The Biotech Showcase 2022 began on January 10th and prominently featured a panel on the use of psychedelics in the treatment of psychological and central nervous system (CNS) disorders. Moderated by Walter Greenleaf; the four panelists discussed the use of MDMA, Psilocybin and LSD for a variety of disorders and the obstacles involved in the endeavor.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23